I strongly endorse the comments received. It is always advisable to control impurities to below the limit of detection (LOD) or ensure they are not detected, particularly in the active pharmaceutical ingredient (API), as drug product excipients may contain traces of nitrites/nitrates—which may not be practically possible to eliminate completely—and the likelihood of impurity formation during the shelf life is higher.